Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Supernus: Q4 Earnings Snapshot AP - Tue Feb 27, 5:02PM CST

Supernus: Q4 Earnings Snapshot

SUPN : 29.67 (-5.21%)
Supernus: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Supernus: Q3 Earnings Snapshot

SUPN : 29.67 (-5.21%)
Supernus: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Supernus: Q2 Earnings Snapshot

SUPN : 29.67 (-5.21%)
Despite 1 Major Headwind and Pricey Shares, This Stock Is Still a Buy Motley Fool - Sat Jun 10, 2023

Supernus Pharmaceuticals' revenue mix is shifting, and it could soon have more sales on the way.

SUPN : 29.67 (-5.21%)
Supernus (SUPN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks - Tue May 9, 2023

The headline numbers for Supernus (SUPN) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates...

SUPN : 29.67 (-5.21%)
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates Zacks - Tue May 9, 2023

Supernus (SUPN) delivered earnings and revenue surprises of 141.67% and 8.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 29.67 (-5.21%)
MYO : 3.63 (-7.63%)
Supernus: Q1 Earnings Snapshot AP - Tue May 9, 2023

Supernus: Q1 Earnings Snapshot

SUPN : 29.67 (-5.21%)
BridgeBio Pharma (BBIO) Reports Q1 Loss, Lags Revenue Estimates Zacks - Thu May 4, 2023

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -9.52% and 74.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BBIO : 28.45 (+2.71%)
SUPN : 29.67 (-5.21%)
Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates Zacks - Tue Feb 28, 2023

Supernus (SUPN) delivered earnings and revenue surprises of -41.10% and 8.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 29.67 (-5.21%)
FIXX : 16.8246 (+0.77%)
Supernus: Q4 Earnings Snapshot AP - Tue Feb 28, 2023

Supernus: Q4 Earnings Snapshot

SUPN : 29.67 (-5.21%)

Barchart Exclusives

1 Cheap Gold Mining Stock to Scoop Up Now Barchart - 20 minutes ago
New Gold is an intermediate gold mining stock that trades at a cheap valuation in 2024. Here's why NGD stock still looks like a bargain, even as it rallies above Wall Street's mean price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot